Regional implementation of atrial fibrillation screening: benefits and pitfalls
- PMID: 36710905
- PMCID: PMC9779812
- DOI: 10.1093/ehjdh/ztac055
Regional implementation of atrial fibrillation screening: benefits and pitfalls
Abstract
Aims: Despite general awareness that screening for atrial fibrillation (AF) could reduce health hazards, large-scale implementation is lagging behind technological developments. As the successful implementation of a screening programme remains challenging, this study aims to identify facilitating and inhibiting factors from healthcare providers' perspectives.
Methods and results: A mixed-methods approach was used to gather data among practice nurses in primary care in the southern region of the Netherlands to evaluate the implementation of an ongoing single-lead electrocardiogram (ECG)-based AF screening programme. Potential facilitating and inhibiting factors were evaluated using online questionnaires (N = 74/75%) and 14 (of 24) semi-structured in-depth interviews (58.3%). All analyses were performed using SPSS 26.0. In total, 16 682 screenings were performed on an eligible population of 64 000, and 100 new AF cases were detected. Facilitating factors included 'receiving clear instructions' (mean ± SD; 4.12 ± 1.05), 'easy use of the ECG-based device' (4.58 ± 0.68), and 'patient satisfaction' (4.22 ± 0.65). Inhibiting factors were 'time availability' (3.20 ± 1.10), 'insufficient feedback to the practice nurse' (2.15 ± 0.89), 'absence of coordination' (54%), and the 'lack of fitting policy' (32%).
Conclusion: Large-scale regional implementation of an AF screening programme in primary care resulted in a low participation of all eligible patients. Based on the perceived barriers by healthcare providers, future AF screening programmes should create preconditions to fit the intervention into daily routines, appointing an overall project lead and a General Practitioner (GP) as a coordinator within every GP practice.
Keywords: Atrial fibrillation; Evaluation; Screening programme; Single-lead-handheld ECG-based screening device.
© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology.
Conflict of interest statement
Conflict of interest: Despite the funding of the single-lead ECG-based devices by Bayer and Boehringer Ingelheim, these pharmaceutical companies were not involved in the implementation or evaluation of the screening programme, and they had no involvement in evaluating and analysing the data or writing this manuscript. The authors declare there were no further conflicts of interest.
Figures
Similar articles
-
A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study.Health Technol Assess. 2005 Oct;9(40):iii-iv, ix-x, 1-74. doi: 10.3310/hta9400. Health Technol Assess. 2005. PMID: 16202350 Clinical Trial.
-
Cost-effectiveness of screening for atrial fibrillation in primary care with a handheld, single-lead electrocardiogram device in the Netherlands.Europace. 2018 Jan 1;20(1):12-18. doi: 10.1093/europace/euw285. Europace. 2018. PMID: 27733465
-
Uptake of a primary care atrial fibrillation screening program (AF-SMART): a realist evaluation of implementation in metropolitan and rural general practice.BMC Fam Pract. 2019 Dec 6;20(1):170. doi: 10.1186/s12875-019-1058-9. BMC Fam Pract. 2019. PMID: 31810441 Free PMC article.
-
Patient-Led Mass Screening for Atrial Fibrillation in the Older Population Using Handheld Electrocardiographic Devices Integrated With a Clinician-Coordinated Remote Central Monitoring System: Protocol for a Randomized Controlled Trial and Process Evaluation.JMIR Res Protoc. 2022 Feb 1;11(2):e34778. doi: 10.2196/34778. JMIR Res Protoc. 2022. PMID: 35103614 Free PMC article.
-
Opportunistic atrial fibrillation screening and detection in "self-service health check-up stations": a brief overview of current technology potential and possibilities.Mhealth. 2021 Jan 20;7:12. doi: 10.21037/mhealth-19-204. eCollection 2021. Mhealth. 2021. PMID: 33634195 Free PMC article. Review.
Cited by
-
Screening and detection of atrial fibrillation in primary care: current practice and future perspectives.Eur Heart J Suppl. 2024 Jul 31;26(Suppl 4):iv12-iv18. doi: 10.1093/eurheartjsupp/suae074. eCollection 2024 Jul. Eur Heart J Suppl. 2024. PMID: 39099572 Free PMC article.
-
The role of atrial fibrillation in vascular cognitive impairment and dementia: epidemiology, pathophysiology, and preventive strategies.Geroscience. 2025 Feb;47(1):287-300. doi: 10.1007/s11357-024-01290-1. Epub 2024 Aug 13. Geroscience. 2025. PMID: 39138793 Free PMC article. Review.
References
-
- Himmelreich JCL, Lucassen WAM, Harskamp RE. CHARGE-AF in a national routine primary care electronic health records database in the Netherlands: validation for 5-year risk of atrial fibrillation and implications for patient selection in atrial fibrillation screening. Open Heart 2021;8:e001459. - PMC - PubMed
-
- Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. Int J Stroke 2021;16:217–221. - PubMed
-
- Freedman B, Camm J, Calkins H, Healey JS, Rosenqvist M, Wang J, Wijeratne T. Screening for atrial fibrillation: a report of the AF-SCREEN international collaboration. Circulation 2017;135:1851–1867. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials